How much is ElevateBio worth in 2026?

ElevateBio has a current valuation of N/A based on their Later Stage VC (Series D) round and secondary market data.

How much funding has ElevateBio raised?

ElevateBio has raised N/A in total funding across 2 funding rounds.

ElevateBio

Discovery Tools (Healthcare)

ElevateBio valuation and funding history | Last updated: May 24, 2023 | 2 funding rounds

Current Valuation

N/A

As of May 24, 2023

Total Funding Raised

N/A

Across 2 rounds

Last Round

Later Stage VC (Series D)

$401.0M

Last Funding

May 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 24, 2023	Later Stage VC (Series D)	$401.0M	N/A	-
January 15, 2021	Later Stage VC (Series C)	$525.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

ElevateBio is currently valued at N/A as of May 24, 2023.

Track ElevateBio Valuation Updates

Get notified when ElevateBio raises new funding or valuation changes

Explore More Data

Detailed analysis for ElevateBio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock ElevateBio's valuation history, funding rounds, and growth metrics.

No credit card required

What is ElevateBio Worth in 2026?

ElevateBio is a leading private company in the Discovery Tools (Healthcare) sector. Track ElevateBio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How ElevateBio Valuation is Determined

Private company valuations like ElevateBio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.